83
Participants
Start Date
May 15, 2023
Primary Completion Date
July 2, 2024
Study Completion Date
December 31, 2029
Teropavimab
Administered intravenously
Zinlirvimab
Administered intravenously
Lenacapavir Tablet
Administered orally
Lenacapavir Injection
Administered subcutaneously
Antiretroviral Therapy
Antiretroviral therapy, administered orally may include regimens such as: bictegravir/emtricitabine/tenofovir alafenamide, darunavir/cobicistat/emtricitabine/tenofovir alafenamide, dolutegravir/abacavir lamivudine, and rilpivirine/emtricitabine/tenofovir alafenamide.
Clinical Research Puerto Rico, San Juan
East Sydney Doctors, Darlinghurst
Alfred Hospital, Melbourne
Montefiore Medical Center, The Bronx
Georgetown University Medical Center, Washington D.C.
Clinical Alliance for Research & Education, Infectious Diseases LLC (CARE-ID), Annandale
Regional Center for Infectious Disease Research, Greensboro
NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill, Chapel Hill
Duke University Health Center, Durham
The Brody School of Medicine at East Carolina University, Greenville
Rosedale Health and Wellness, Huntersville
Prisma Health - Clinical Research Unit, Columbia
Infectious Disease Specialists of Atlanta, Decatur
Emory University Hospital Midtown Infectious Disease Clinic, Atlanta
Midland Florida Clinical Research Center, LLC, DeLand
Orlando Immunology Center, Orlando
Can Community Health Care, Fort Lauderdale
Triple O Research Institute, P.A., West Palm Beach
Midway Immunology and Research Center, Ft. Pierce
St Jude Children's Research Hospital, Memphis
Southhampton Healthcare, Inc, St Louis
AIDS Arms, Inc. DBA Prism Health North Texas, Dallas
The Crofoot Research Center, INC, Houston
Central Texas Clinical Research, Austin
AXCES Research Group, LLC, El Paso
University of Colorado Clinical and Translational Research Center, Aurora
AXCES Research Group, LLC, Albuquerque
Ruane Clinical Research Group, Inc., Los Angeles
Mills Clinical Research, Los Angeles
UC San Diego (UCSD) AntiViral Research Center (AVRC), San Diego
Optimus Medical Group, San Francisco
Yale University; School of Medicine; AIDS Program, New Haven
Holdsworth House Medical Practice, Sydney
Maple Leaf Research/Maple Leaf Medical Clinic, Toronto
Lead Sponsor
Gilead Sciences
INDUSTRY